Iovance Biotherapeutics Aktie

Kaufen

Verkaufen

Handeln Handeln

Aktien-Sparplan anlegen Aktien-Sparplan anlegen

2,23 EUR -0,11 EUR -4,54 %

22:13:27

BMN

2,57 USD -0,11 USD -3,93 %

21:59:58

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.778,22 Mio. EUR

Div. Rendite0,00%

WKNA2DT49

ISINUS4622601007

SymbolIOVA

Iovance Biotherapeutics Aktien News

Sortieren:Datum Meistgelesen

23.11.24MotleyFoolGot $1,500? Buy Iovance Biotherapeutics Now and Don't Look Back

07.11.24ZacksIovance Biotherapeutics (IOVA) Reports Q3 Loss, Tops Revenue Estimates

25.10.24MotleyFoolWhy Iovance Biotherapeutics Stock Triumphed on Thursday

04.10.24MotleyFoolIs Iovance Biotherapeutics Stock a Buy?

26.09.24MotleyFool3 Reasons to Buy Iovance Biotherapeutics Stock Like There's No Tomorrow

16.09.24MotleyFool3 Things You Need to Know if You Buy Iovance Biotherapeutics Today

06.09.24MotleyFoolThis Is the Biggest Risk With Iovance Biotherapeutics Stock

27.08.24MotleyFoolUp 47% in 2024: Where Will Iovance Biotherapeutics Be in 5 Years?

14.08.24MotleyFoolThis 1 Big Risk Is Also 1 Big Opportunity for Iovance Biotherapeutics Stock

12.08.24BenzingaIovance Biotherapeutics Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)

09.08.24MotleyFoolWhy Iovance Biotherapeutics Shares Are Soaring Today

09.08.24BenzingaSkin Cancer-Focused Iovance Biotherapeutics Reports Better-Than-Expected 2024, 2025 Outlook, Stock Surges

08.08.24ZacksIovance Biotherapeutics (IOVA) Reports Q2 Loss, Tops Revenue Estimates

08.08.24BenzingaWhat the Options Market Tells Us About Iovance Biotherapeutics

01.08.24ZacksIovance Biotherapeutics (IOVA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

31.07.24MotleyFoolIovance Biotherapeutics Attracted a Downgrade. Is It Time to Sell?

30.07.24MotleyFoolWhy Iovance Biotherapeutics Stock Stumbled Today

29.07.24BenzingaIovance Biotherapeutics Price Forecast Slashed By 40% On Mutated Uptake For Its Newly Approved Skin Cancer Cell Therapy

23.01.24PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Iovance Biotherapeutics, Inc. - IOVA

14.01.24PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Iovance Biotherapeutics, Inc. - IOVA

06.01.24PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Iovance Biotherapeutics, Inc. - IOVA

28.12.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Iovance Biotherapeutics, Inc. - IOVA

Iovance Biotherapeutics News

Iovance Biotherapeutics News: auf dieser Seite finden Sie alle Iovance Biotherapeutics News und Nachrichten zur Iovance Biotherapeutics Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Iovance Biotherapeutics News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Iovance Biotherapeutics News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.